ING Groep NV Sells 18,054 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

ING Groep NV trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 25.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 54,194 shares of the medical equipment provider's stock after selling 18,054 shares during the quarter. ING Groep NV's holdings in Intuitive Surgical were worth $28,287,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $26,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $36,000. Sierra Ocean LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $40,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the firm's stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company's stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 408 shares of the business's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $1.84 during mid-day trading on Monday, reaching $593.63. 653,802 shares of the company were exchanged, compared to its average volume of 1,693,389. The business has a 50 day simple moving average of $565.45 and a two-hundred day simple moving average of $525.60. The stock has a market capitalization of $211.44 billion, a PE ratio of 92.53, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ISRG shares. Jefferies Financial Group boosted their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Evercore ISI raised their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, Piper Sandler reissued an "overweight" rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.